Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study
Participants in the HCL group maintained 70% TIR during the first 6 months postpartum, supporting continued use of HCL rather than standard insulin therapy for people with diabetes once they have given birth.